The effect of alogliptin and pioglitazone combination therapy on various aspects of beta-cell function in patients with recent-onset type 2 diabetes

D.H. van Raalte, R.E. van Genugten, B. Eliasson, D.L. Moller-Goede, A. Mari, A. Tura, C. Wilson, P. Fleck, M.R. Taskinen, U. Smith, M. Diamant

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)565-574
JournalEuropean Journal of Endocrinology
Issue number4
Publication statusPublished - 2014

Cite this